Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges.

4-OHPBN N-acetyl-L-cysteine NXY-059 PBN antioxidants free radicals sensorineural hearing loss

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2021
Historique:
received: 18 05 2021
accepted: 11 08 2021
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

Nitrones are potent antioxidant molecules able to reduce oxidative stress by trapping reactive oxygen and nitrogen species. The antioxidant potential of nitrones has been extensively tested in multiple models of human diseases. Sensorineural hearing loss has a heterogeneous etiology, genetic alterations, aging, toxins or exposure to noise can cause damage to hair cells at the organ of Corti, the hearing receptor. Noxious stimuli share a battery of common mechanisms by which they cause hair cell injury, including oxidative stress, the generation of free radicals and redox imbalance. Therefore, targeting oxidative stress-mediated hearing loss has been the subject of much attention. Here we review the chemistry of nitrones, the existing literature on their use as antioxidants and the general state of the art of antioxidant treatments for hearing loss.

Identifiants

pubmed: 34539349
doi: 10.3389/fncel.2021.711269
pmc: PMC8440819
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

711269

Informations de copyright

Copyright © 2021 Varela-Nieto, Murillo-Cuesta, Rodríguez-de la Rosa, Oset-Gasque and Marco-Contelles.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Ther. 2004 Feb;9(2):173-81
pubmed: 14759801
Med Res Rev. 2018 Jul;38(4):1159-1187
pubmed: 29095519
Hear Res. 2017 Dec 14;358:10-21
pubmed: 29304389
Hear Res. 2007 Apr;226(1-2):44-51
pubmed: 17030476
J Transl Med. 2020 Nov 10;18(1):424
pubmed: 33168005
Aging Cell. 2020 Dec;19(12):e13275
pubmed: 33222382
Toxicol Appl Pharmacol. 1997 Jan;142(1):47-55
pubmed: 9007033
Toxicol Sci. 2002 Mar;66(1):131-8
pubmed: 11861980
Curr Med Chem. 2011;18(25):3871-88
pubmed: 21824100
Toxicol Appl Pharmacol. 2000 Sep 1;167(2):125-31
pubmed: 10964763
Free Radic Biol Med. 2008 May 1;44(9):1772-84
pubmed: 18328271
Lancet. 2017 Sep 2;390(10098):969-979
pubmed: 28716314
Cold Spring Harb Perspect Med. 2019 Nov 1;9(11):
pubmed: 30559254
J Otol. 2016 Sep;11(3):118-126
pubmed: 29937820
Acta Otolaryngol. 2005 Mar;125(3):235-43
pubmed: 15966690
Hear Res. 2017 Jun;349:129-137
pubmed: 27916698
J Med Chem. 2020 Nov 25;63(22):13413-13427
pubmed: 32869989
J Assoc Res Otolaryngol. 2000 Nov;1(3):243-54
pubmed: 11545230
J Int Adv Otol. 2015 Apr;11(1):12-8
pubmed: 26223711
PLoS One. 2017 Aug 23;12(8):e0183089
pubmed: 28832600
Physiol Rev. 2018 Oct 1;98(4):2477-2522
pubmed: 30156495
Toxicol Sci. 2000 Dec;58(2):315-23
pubmed: 11099644
Proc Soc Exp Biol Med. 1999 Dec;222(3):236-45
pubmed: 10601882
J Toxicol. 2009;2009:908596
pubmed: 20130768
Curr Top Med Chem. 2017;17(18):2006-2022
pubmed: 28260508
Hear Res. 2007 Apr;226(1-2):114-25
pubmed: 17184943
J Assoc Res Otolaryngol. 2014 Jun;15(3):353-72
pubmed: 24497307
J Audiol Otol. 2015 Dec;19(3):111-9
pubmed: 26771008
Hear Res. 2015 May;323:40-50
pubmed: 25620313
Adv Pharmacol. 1997;38:361-78
pubmed: 8895816
Acta Otorrinolaringol Esp (Engl Ed). 2019 Nov - Dec;70(6):373-375
pubmed: 30851870
Int J Otolaryngol. 2011;2011:612690
pubmed: 21961007
Free Radic Biol Med. 2019 May 1;135:46-59
pubmed: 30802489
Expert Opin Drug Discov. 2020 Dec;15(12):1457-1471
pubmed: 32838572
Future Med Chem. 2012 Jun;4(9):1171-207
pubmed: 22709256
J Biol Chem. 1973 May 25;248(10):3582-92
pubmed: 4702877
Front Neurol. 2021 Feb 09;12:635359
pubmed: 33633679
Hear Res. 1982 Feb;6(2):141-51
pubmed: 7061348
Neuropharmacology. 2007 May;52(6):1426-37
pubmed: 17449343
Eur J Pharmacol. 2020 Mar 15;871:172926
pubmed: 31958456
Toxicol Appl Pharmacol. 2005 Apr 1;204(1):46-56
pubmed: 15781293
Clin Transl Med. 2021 Apr;11(4):e363
pubmed: 33931965
Elife. 2019 Apr 02;8:
pubmed: 30938680
Free Radic Biol Med. 2008 Nov 15;45(10):1361-74
pubmed: 18793715
J Assoc Res Otolaryngol. 2004 Mar;5(1):90-8
pubmed: 14669069
Nitric Oxide. 2011 Oct 30;25(3):309-15
pubmed: 21645628
Hear Res. 2020 Mar 15;388:107880
pubmed: 31945692

Auteurs

Isabel Varela-Nieto (I)

Institute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Hospital La Paz Institute for Health Research, Madrid, Spain.

Silvia Murillo-Cuesta (S)

Institute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Hospital La Paz Institute for Health Research, Madrid, Spain.

Lourdes Rodríguez-de la Rosa (L)

Institute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Hospital La Paz Institute for Health Research, Madrid, Spain.

María Jesús Oset-Gasque (MJ)

Department of Biochemistry and Molecular Biology, School of Pharmacy, Complutense University of Madrid, Madrid, Spain.
Institute of Neurochemistry Research, Complutense University of Madrid, Madrid, Spain.

José Marco-Contelles (J)

Laboratory of Medicinal Chemistry, Institute of General Organic Chemistry, CSIC, Madrid, Spain.

Classifications MeSH